{"pmid":32183934,"title":"Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020.","text":["Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020.","Since December 2019, 62 medical staff of Zhongnan Hospital in Wuhan, China have been hospitalised with coronavirus disease 2019. During the post-discharge surveillance after clinical recovery, swabs were positive in two asymptomatic cases (3.23%). Case 1 had presented typical clinical and radiological manifestations on admission, while manifestation in Case 2 was very mild. In conclusion, a small proportion of recovered patients may test positive after discharge, and post-discharge surveillance and isolation need to be strengthened.","Euro Surveill","Xing, Yuanyuan","Mo, Pingzheng","Xiao, Yu","Zhao, Oiu","Zhang, Yongxi","Wang, Fan","32183934"],"abstract":["Since December 2019, 62 medical staff of Zhongnan Hospital in Wuhan, China have been hospitalised with coronavirus disease 2019. During the post-discharge surveillance after clinical recovery, swabs were positive in two asymptomatic cases (3.23%). Case 1 had presented typical clinical and radiological manifestations on admission, while manifestation in Case 2 was very mild. In conclusion, a small proportion of recovered patients may test positive after discharge, and post-discharge surveillance and isolation need to be strengthened."],"journal":"Euro Surveill","authors":["Xing, Yuanyuan","Mo, Pingzheng","Xiao, Yu","Zhao, Oiu","Zhang, Yongxi","Wang, Fan"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32183934","week":"202012|Mar 16 - Mar 22","doi":"10.2807/1560-7917.ES.2020.25.10.2000191","keywords":["COVID-19","medical staff","positive detection","post-discharge surveillance"],"source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1661633092408836097,"score":6.786717,"similar":[{"pmid":32146694,"title":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.","text":["Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.","Previous studies have showed clinical characteristics of patients with the 2019 novel coronavirus disease (COVID-19) and the evidence of person-to-person transmission. Limited data are available for asymptomatic infections. This study aims to present the clinical characteristics of 24 cases with asymptomatic infection screened from close contacts and to show the transmission potential of asymptomatic COVID-19 virus carriers. Epidemiological investigations were conducted among all close contacts of COVID-19 patients (or suspected patients) in Nanjing, Jiangsu Province, China, from Jan 28 to Feb 9, 2020, both in clinic and in community. Asymptomatic carriers were laboratory-confirmed positive for the COVID-19 virus by testing the nucleic acid of the pharyngeal swab samples. Their clinical records, laboratory assessments, and chest CT scans were reviewed. As a result, none of the 24 asymptomatic cases presented any obvious symptoms while nucleic acid screening. Five cases (20.8%) developed symptoms (fever, cough, fatigue, etc.) during hospitalization. Twelve (50.0%) cases showed typical CT images of ground-glass chest and 5 (20.8%) presented stripe shadowing in the lungs. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization. These 7 cases were younger (median age: 14.0 years; P=0.012) than the rest. None of the 24 cases developed severe COVID-19 pneumonia or died. The median communicable period, defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests, was 9.5 days (up to 21 days among the 24 asymptomatic cases). Through epidemiological investigation, we observed a typical asymptomatic transmission to the cohabiting family members, which even caused severe COVID-19 pneumonia. Overall, the asymptomatic carriers identified from close contacts were prone to be mildly ill during hospitalization. However, the communicable period could be up to three weeks and the communicated patients could develop severe illness. These results highlighted the importance of close contact tracing and longitudinally surveillance via virus nucleic acid tests. Further isolation recommendation and continuous nucleic acid tests may also be recommended to the patients discharged.","Sci China Life Sci","Hu, Zhiliang","Song, Ci","Xu, Chuanjun","Jin, Guangfu","Chen, Yaling","Xu, Xin","Ma, Hongxia","Chen, Wei","Lin, Yuan","Zheng, Yishan","Wang, Jianming","Hu, Zhibin","Yi, Yongxiang","Shen, Hongbing","32146694"],"abstract":["Previous studies have showed clinical characteristics of patients with the 2019 novel coronavirus disease (COVID-19) and the evidence of person-to-person transmission. Limited data are available for asymptomatic infections. This study aims to present the clinical characteristics of 24 cases with asymptomatic infection screened from close contacts and to show the transmission potential of asymptomatic COVID-19 virus carriers. Epidemiological investigations were conducted among all close contacts of COVID-19 patients (or suspected patients) in Nanjing, Jiangsu Province, China, from Jan 28 to Feb 9, 2020, both in clinic and in community. Asymptomatic carriers were laboratory-confirmed positive for the COVID-19 virus by testing the nucleic acid of the pharyngeal swab samples. Their clinical records, laboratory assessments, and chest CT scans were reviewed. As a result, none of the 24 asymptomatic cases presented any obvious symptoms while nucleic acid screening. Five cases (20.8%) developed symptoms (fever, cough, fatigue, etc.) during hospitalization. Twelve (50.0%) cases showed typical CT images of ground-glass chest and 5 (20.8%) presented stripe shadowing in the lungs. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization. These 7 cases were younger (median age: 14.0 years; P=0.012) than the rest. None of the 24 cases developed severe COVID-19 pneumonia or died. The median communicable period, defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests, was 9.5 days (up to 21 days among the 24 asymptomatic cases). Through epidemiological investigation, we observed a typical asymptomatic transmission to the cohabiting family members, which even caused severe COVID-19 pneumonia. Overall, the asymptomatic carriers identified from close contacts were prone to be mildly ill during hospitalization. However, the communicable period could be up to three weeks and the communicated patients could develop severe illness. These results highlighted the importance of close contact tracing and longitudinally surveillance via virus nucleic acid tests. Further isolation recommendation and continuous nucleic acid tests may also be recommended to the patients discharged."],"journal":"Sci China Life Sci","authors":["Hu, Zhiliang","Song, Ci","Xu, Chuanjun","Jin, Guangfu","Chen, Yaling","Xu, Xin","Ma, Hongxia","Chen, Wei","Lin, Yuan","Zheng, Yishan","Wang, Jianming","Hu, Zhibin","Yi, Yongxiang","Shen, Hongbing"],"date":"2020-03-09T11:00:00Z","year":2020,"_id":"32146694","week":"202011|Mar 09 - Mar 15","doi":"10.1007/s11427-020-1661-4","keywords":["COVID-19","China","asymptomatic infections","close contact"],"source":"PubMed","locations":["Jiangsu","Nanjing","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1661359647780503552,"score":123.35299},{"pmid":32070465,"pmcid":"PMC7029452","title":"First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.","text":["First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.","A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) causing a cluster of respiratory infections (coronavirus disease 2019, COVID-19) in Wuhan, China, was identified on 7 January 2020. The epidemic quickly disseminated from Wuhan and as at 12 February 2020, 45,179 cases have been confirmed in 25 countries, including 1,116 deaths. Strengthened surveillance was implemented in France on 10 January 2020 in order to identify imported cases early and prevent secondary transmission. Three categories of risk exposure and follow-up procedure were defined for contacts. Three cases of COVID-19 were confirmed on 24 January, the first cases in Europe. Contact tracing was immediately initiated. Five contacts were evaluated as at low risk of exposure and 18 at moderate/high risk. As at 12 February 2020, two cases have been discharged and the third one remains symptomatic with a persistent cough, and no secondary transmission has been identified. Effective collaboration between all parties involved in the surveillance and response to emerging threats is required to detect imported cases early and to implement adequate control measures.","Euro Surveill","Bernard Stoecklin, Sibylle","Rolland, Patrick","Silue, Yassoungo","Mailles, Alexandra","Campese, Christine","Simondon, Anne","Mechain, Matthieu","Meurice, Laure","Nguyen, Mathieu","Bassi, Clement","Yamani, Estelle","Behillil, Sylvie","Ismael, Sophie","Nguyen, Duc","Malvy, Denis","Lescure, Francois Xavier","Georges, Scarlett","Lazarus, Clement","Tabai, Anouk","Stempfelet, Morgane","Enouf, Vincent","Coignard, Bruno","Levy-Bruhl, Daniel","Investigation Team","32070465"],"abstract":["A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) causing a cluster of respiratory infections (coronavirus disease 2019, COVID-19) in Wuhan, China, was identified on 7 January 2020. The epidemic quickly disseminated from Wuhan and as at 12 February 2020, 45,179 cases have been confirmed in 25 countries, including 1,116 deaths. Strengthened surveillance was implemented in France on 10 January 2020 in order to identify imported cases early and prevent secondary transmission. Three categories of risk exposure and follow-up procedure were defined for contacts. Three cases of COVID-19 were confirmed on 24 January, the first cases in Europe. Contact tracing was immediately initiated. Five contacts were evaluated as at low risk of exposure and 18 at moderate/high risk. As at 12 February 2020, two cases have been discharged and the third one remains symptomatic with a persistent cough, and no secondary transmission has been identified. Effective collaboration between all parties involved in the surveillance and response to emerging threats is required to detect imported cases early and to implement adequate control measures."],"journal":"Euro Surveill","authors":["Bernard Stoecklin, Sibylle","Rolland, Patrick","Silue, Yassoungo","Mailles, Alexandra","Campese, Christine","Simondon, Anne","Mechain, Matthieu","Meurice, Laure","Nguyen, Mathieu","Bassi, Clement","Yamani, Estelle","Behillil, Sylvie","Ismael, Sophie","Nguyen, Duc","Malvy, Denis","Lescure, Francois Xavier","Georges, Scarlett","Lazarus, Clement","Tabai, Anouk","Stempfelet, Morgane","Enouf, Vincent","Coignard, Bruno","Levy-Bruhl, Daniel","Investigation Team"],"date":"2020-02-20T11:00:00Z","year":2020,"_id":"32070465","week":"20208|Feb 17 - Feb 23","doi":"10.2807/1560-7917.ES.2020.25.6.2000094","keywords":["COVID-19, SARS-CoV-2, 2019-nCov","France","Surveillance","contact tracing","containment","coronavirus"],"source":"PubMed","locations":["France","Wuhan","China"],"countries":["France","China"],"countries_codes":["FRA|France","CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1661359647323324417,"score":121.045815},{"pmid":32168162,"title":"A Diabetic Patient With 2019-nCoV Infection Who Recovered and Was Discharged From Hospital.","text":["A Diabetic Patient With 2019-nCoV Infection Who Recovered and Was Discharged From Hospital.","Novel coronavirus has become a global health hazard and its high infectivity is alarming. The imaging findings of the 2019-nCoV infection in our young diabetic patient featured ground-glass opacities and consolidations in both lungs. The lung lesions may involute rapidly during the course. The patient showed improvement both clinically and on computed tomography imaging at discharged after 2 weeks'treatment. Computed tomography scans of patients helped monitor the changes continuously, which could timely provide the information of the evolution of the disease or therapeutic effect to clinicians.","J Thorac Imaging","Han, Xiaoyu","Fan, Yanqing","Wan, Yung-Liang","Shi, Heshui","32168162"],"abstract":["Novel coronavirus has become a global health hazard and its high infectivity is alarming. The imaging findings of the 2019-nCoV infection in our young diabetic patient featured ground-glass opacities and consolidations in both lungs. The lung lesions may involute rapidly during the course. The patient showed improvement both clinically and on computed tomography imaging at discharged after 2 weeks'treatment. Computed tomography scans of patients helped monitor the changes continuously, which could timely provide the information of the evolution of the disease or therapeutic effect to clinicians."],"journal":"J Thorac Imaging","authors":["Han, Xiaoyu","Fan, Yanqing","Wan, Yung-Liang","Shi, Heshui"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32168162","week":"202011|Mar 09 - Mar 15","doi":"10.1097/RTI.0000000000000506","source":"PubMed","topics":["Case Report","Diagnosis","Treatment"],"weight":1,"_version_":1661359647954567170,"score":115.900856},{"pmid":32131151,"title":"[Mental health survey of 230 medical staff in a tertiary infectious disease hospital for COVID-19].","text":["[Mental health survey of 230 medical staff in a tertiary infectious disease hospital for COVID-19].","Objective: To investigate the mental health of clinical first-line medical staff in COVID-19 epidemic and provide theoretical basis for psychological intervention. Method: The mental health status of the first-line medical staff was investigated by Self-rating Anxiety Acale (SAS) and Post-Traumatic Stress Disorder Self-rating Scale(PTSD-SS). From February 7 to 14, 2020, 246 medical staff were investigated who participated in the treatment of COVID-19 using cluster sampling , and received 230 responses, with a recovery rate of 93.5%. Results: The incidence of anxiety in medical staff was 23.04% (53/230), and the score of SAS was (42.91 +/- 10.89). Among them, the incidence of severe anxiety, moderate anxiety and mild anxiety were 2.17% (5/230), 4.78% (11/230) and 16.09% (37/230), respectively. The incidence of anxiety in female medical staff was higher than that in male [25.67% (48/187) vs 11.63% (5/43), Z=-2.008, P=0.045], the score of SAS in female medical staff was higher than that in male [(43.78+/-11.12) vs (39.14 +/- 9.01), t =-2.548, P=0.012]. The incidence of anxiety in nurses was higher than that in doctors [26.88% (43/160) vs 14.29% (10/70), Z=-2.066, P=0.039], and the score of SAS in nurses was higher than that in doctors [(44.84+/-10.42) vs (38.50+/-10.72), t =-4.207, P<0.001]. The incidence of stress disorder in medical staff was 27.39% (63/230), and the score of PTSD-SS was (42.92 +/- 17.88). The score of PTSD-SS in female medical staff was higher than that of male [(44.30+/-18.42) vs(36.91 +/- 13.95), t=-2.472, P=0.014]. Conclusions: In COVID-19 epidemic, the incidence of anxiety and stress disorder is high among medical staff. Medical institutions should strengthen the training of psychological skills of medical staff. Special attention should be paid to the mental health of female nurses.","Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi","Huang, J Z","Han, M F","Luo, T D","Ren, A K","Zhou, X P","32131151"],"abstract":["Objective: To investigate the mental health of clinical first-line medical staff in COVID-19 epidemic and provide theoretical basis for psychological intervention. Method: The mental health status of the first-line medical staff was investigated by Self-rating Anxiety Acale (SAS) and Post-Traumatic Stress Disorder Self-rating Scale(PTSD-SS). From February 7 to 14, 2020, 246 medical staff were investigated who participated in the treatment of COVID-19 using cluster sampling , and received 230 responses, with a recovery rate of 93.5%. Results: The incidence of anxiety in medical staff was 23.04% (53/230), and the score of SAS was (42.91 +/- 10.89). Among them, the incidence of severe anxiety, moderate anxiety and mild anxiety were 2.17% (5/230), 4.78% (11/230) and 16.09% (37/230), respectively. The incidence of anxiety in female medical staff was higher than that in male [25.67% (48/187) vs 11.63% (5/43), Z=-2.008, P=0.045], the score of SAS in female medical staff was higher than that in male [(43.78+/-11.12) vs (39.14 +/- 9.01), t =-2.548, P=0.012]. The incidence of anxiety in nurses was higher than that in doctors [26.88% (43/160) vs 14.29% (10/70), Z=-2.066, P=0.039], and the score of SAS in nurses was higher than that in doctors [(44.84+/-10.42) vs (38.50+/-10.72), t =-4.207, P<0.001]. The incidence of stress disorder in medical staff was 27.39% (63/230), and the score of PTSD-SS was (42.92 +/- 17.88). The score of PTSD-SS in female medical staff was higher than that of male [(44.30+/-18.42) vs(36.91 +/- 13.95), t=-2.472, P=0.014]. Conclusions: In COVID-19 epidemic, the incidence of anxiety and stress disorder is high among medical staff. Medical institutions should strengthen the training of psychological skills of medical staff. Special attention should be paid to the mental health of female nurses."],"journal":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi","authors":["Huang, J Z","Han, M F","Luo, T D","Ren, A K","Zhou, X P"],"date":"2020-03-05T11:00:00Z","year":2020,"_id":"32131151","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.cn121094-20200219-00063","keywords":["Anxiety","COVID-19","Medical staff","Stress disorder, post-traumatic"],"source":"PubMed","locations":["Z=-2.066","Z=-2.008"],"topics":["General Info"],"weight":1,"_version_":1661359647684034560,"score":114.19345},{"pmid":32171867,"title":"Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.","text":["Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.","OBJECTIVES: Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. However, limited data was available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reactivation. This study aimed to evaluate the clinical characteristics of the SARS-CoV-2 reactivation. METHODS: Clinical records, laboratory results, and chest CT scans were retrospectively reviewed for 55 patients with laboratory-confirmed COVID-19 pneumonia (i.e., with throat swab samples that were positive for SARS-CoV-2) who were admitted to Zhongnan Hospital of Wuhan University, Wuhan, China, from Jan. 8 to Feb. 10, 2020. RESULTS: All 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation. Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue. One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56x10(9) cells per L) and progressive neutrophilia (from 4.5 to 18.28x10(9) cells per L). All 5 reactivated patients presented normal aminotransferase levels. Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus. CONCLUSIONS: Findings from this small group of cases suggested that there was currently evidence for reactivation of SARS-CoV-2 and there might be no specific clinical characteristics to distinguish them.","J Infect","Ye, Guangming","Pan, Zhenyu","Pan, Yunbao","Deng, Qiaoling","Chen, Liangjun","Li, Jin","Li, Yirong","Wang, Xinghuan","32171867"],"abstract":["OBJECTIVES: Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. However, limited data was available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reactivation. This study aimed to evaluate the clinical characteristics of the SARS-CoV-2 reactivation. METHODS: Clinical records, laboratory results, and chest CT scans were retrospectively reviewed for 55 patients with laboratory-confirmed COVID-19 pneumonia (i.e., with throat swab samples that were positive for SARS-CoV-2) who were admitted to Zhongnan Hospital of Wuhan University, Wuhan, China, from Jan. 8 to Feb. 10, 2020. RESULTS: All 55 patients had a history of epidemiological exposure to COVID-19, and 5 (9%) patients who discharged from hospital presented with SARS-CoV-2 reactivation. Among the 5 reactivated patients, other symptoms were also observed, including fever, cough, sore throat, and fatigue. One of the 5 patients had progressive lymphopenia (from 1.3 to 0.56x10(9) cells per L) and progressive neutrophilia (from 4.5 to 18.28x10(9) cells per L). All 5 reactivated patients presented normal aminotransferase levels. Throat swab samples from the 5 reactivated patients were tested for SARS-CoV-2, indicating all positive for the virus. CONCLUSIONS: Findings from this small group of cases suggested that there was currently evidence for reactivation of SARS-CoV-2 and there might be no specific clinical characteristics to distinguish them."],"journal":"J Infect","authors":["Ye, Guangming","Pan, Zhenyu","Pan, Yunbao","Deng, Qiaoling","Chen, Liangjun","Li, Jin","Li, Yirong","Wang, Xinghuan"],"date":"2020-03-16T11:00:00Z","year":2020,"_id":"32171867","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.jinf.2020.03.001","keywords":["COVID-19","CT scan","SARS-CoV-2","laboratory medicine"],"source":"PubMed","locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1661518929211686912,"score":112.47343}]}